Jade Biosciences to Participate in Upcoming Conferences

Core Insights - Jade Biosciences, Inc. is focused on developing advanced therapies for autoimmune diseases, with its lead candidate, JADE101, targeting immunoglobulin A nephropathy [3] - The company will participate in several upcoming conferences, including one-on-one investor meetings [1][6] Company Overview - Jade Biosciences is dedicated to addressing unmet needs in autoimmune diseases, with a pipeline that includes JADE101 and a second candidate, JADE201, along with an undisclosed antibody discovery program, JADE-003 [3] - The company was established based on assets licensed from Paragon Therapeutics, an antibody discovery engine [3] Upcoming Events - Jade will host a fireside chat at the Cantor Global Healthcare Conference on September 3, 2025, at 3:20 p.m. ET [6] - The company will also participate in the Stifel Virtual Immunology and Inflammation Forum on September 16, 2025, at 1:00 p.m. ET [6] - Additionally, Jade will be part of the 11th Annual World Medical Innovation Forum on September 16, 2025, at 4:40 p.m. ET [6]